Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -41.28% vs -20.04% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 13.91% vs -3.52% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 10.00% vs 0.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -24.45% vs -10.67% in Mar 2025
Compare Balance Sheet Results of Beryl Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.09
24.05
-18.96
-78.84%
Share Warrants & Outstandings
Total Reserve
4.79
14.45
-9.66
-66.85%
Shareholder's Funds
9.89
38.49
-28.60
-74.31%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
8.89
-8.89
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
8.89
-8.89
-100.00%
Deferred Tax Assets / Liabilities
0.04
-0.00
0.04
0.00%
Other Long Term Liabilities
0.05
0.00
0.05
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.51
0.00
0.51
0.00%
Total Non-Current Liabilities
0.60
8.89
-8.29
-93.25%
Current Liabilities
Trade Payables
1.43
75.72
-74.29
-98.11%
Other Current Liabilities
0.51
0.94
-0.43
-45.74%
Short Term Borrowings
2.39
8.33
-5.94
-71.31%
Short Term Provisions
0.15
0.00
0.15
0.00%
Total Current Liabilities
4.48
85.00
-80.52
-94.73%
Total Liabilities
14.96
132.38
-117.42
-88.70%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
14.94
0.13
14.81
11,392.31%
Less: Accumulated Depreciation
8.39
0.08
8.31
10,387.50%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
6.55
0.05
6.50
13,000.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.22
0.00
0.22
0.00%
Long Term Loans & Advances
0.19
0.00
0.19
0.00%
Other Non Current Assets
0.91
0.00
0.91
0.00%
Total Non-Current Assets
8.13
0.05
8.08
16,160.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.13
27.43
-24.30
-88.59%
Sundry Debtors
2.09
46.28
-44.19
-95.48%
Cash and Bank
0.27
0.43
-0.16
-37.21%
Other Current Assets
1.01
1.14
-0.13
-11.40%
Short Term Loans and Advances
0.33
57.05
-56.72
-99.42%
Total Current Assets
6.83
132.33
-125.50
-94.84%
Net Current Assets (Including Current Investments)
2.35
47.33
-44.98
-95.03%
Total Current Assets Excluding Current Investments
6.83
132.33
-125.50
-94.84%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
14.96
132.38
-117.42
-88.70%
Contingent Liabilities
0.30
0.00
0.30
0.00%
Total Debt
2.39
17.22
-14.83
-86.12%
Book Value per share (adjusted)
19.41
16.01
3.40
21.24%
Annual - Borrowings
Borrowings 2.39 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -41.28% vs -20.04% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 6.55 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.91% vs -3.52% in Mar 2025
Annual - Investments
Investments 0.22 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.00% vs 0.00% in Mar 2025
Annual - Current Assets
Current Assets 6.83 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -24.45% vs -10.67% in Mar 2025
Footer loading
